Enhancement of oral bioavailability of drugs using lipid-based carriers: a meta-analysis study

Drug Dev Ind Pharm. 2020 Dec;46(12):2105-2110. doi: 10.1080/03639045.2020.1851245. Epub 2020 Nov 23.

Abstract

Cancer is the disease of this era. Its therapy is moving through ups and downs not only due to poor effectiveness of many treating drugs, but also due to the serious side effects always evolving. In an attempt to overcome this problem, many systems, including lipid-based carriers, have been exploited for their oral delivery. Throughout this study, the meta-analysis tool was used to combine data from different studies and extract evidences that lipid-based carriers enhance the oral bioavailability. Consequently, increasing the efficiency and the reduction in side effects of drugs would follow. Accordingly, the usual parameter to indicate the bioavailability; the area under effect curve (AUC) was used where the lipid carriers have proven their superiority over conventional formulations. Interestingly, by comparing microemulsion/self-microemulsifying system (SMEDDS) versus liposomes/pro-liposomes as subgroups of the meta-analysis study, insignificant differences were recorded between them.

Keywords: Lipid-based carriers;; SMEDDS;; liposomes;; meta-analysis; microemulsion;; pro-liposomes;.

Publication types

  • Meta-Analysis

MeSH terms

  • Administration, Oral
  • Biological Availability
  • Drug Delivery Systems*
  • Lipids*
  • Solubility

Substances

  • Lipids